Approval · Notice of Compliance 1729 · 2003
KEPPRA: Notice of Compliance 1729
Issued March 6, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1729
- Date
- March 6, 2003
- Company
- Ucb Pharma Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Anti-epileptic
Products in this notice
Medicinal ingredients
- LEVETIRACETAM 250 MG per TAB
- LEVETIRACETAM 500 MG per TAB
- LEVETIRACETAM 750 MG per TAB